Molecular Medicine

, Volume 20, Issue 1, pp 17–28 | Cite as

Underexpressed CNDP2 Participates in Gastric Cancer Growth Inhibition through Activating the MAPK Signaling Pathway

  • Zhenwei Zhang
  • Lei Miao
  • Xiaoming Xin
  • Jianpeng Zhang
  • Shengsheng Yang
  • Mingyong Miao
  • Xiangping Kong
  • Binghua Jiao
Research Article


Increasing evidence suggests that cytosolic non-specific dipeptidase 2 (CNDP2) appears to do more than just perform an enzymatic activity; it is functionally important in cancers as well. Here, we show that the expression of CNDP2 is commonly down-regulated in gastric cancer tissues. The ectopic expression of CNDP2 resulted in significant inhibition of cell proliferation, induction of cell apoptosis and cell cycle arrest, and suppressed gastric tumor growth in nude mice. We further revealed that the reintroduction of CNDP2 transcriptionally upregulated p38 and activated c-Jun NH2-terminal kinase (JNK), whereas the loss of CNDP2 increased the phosphorylation of extracellular signal-related kinase (ERK). These results suggest that CNDP2 acts as a functional tumor suppressor in gastric cancer via activation of the mitogen-activated protein kinase (MAPK) pathway.


  1. 1.
    Ushijima T, Sasako M. (2004) Focus on gastric cancer. Cancer Cell. 5:121–5.CrossRefPubMedGoogle Scholar
  2. 2.
    Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. (2009) Gastric cancer. Lancet. 374:477–90.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Bayani J, et al. (2007) Genomic mechanisms and measurement of structural and numerical instability in cancer cells. Semin. Cancer Biol. 17:5–18.CrossRefPubMedGoogle Scholar
  4. 4.
    Johnson GL, Lapadat R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 298:1911–2.CrossRefGoogle Scholar
  5. 5.
    Liang B, et al. (2005) Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer. World J. Gastroenterol. 11:623–8.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Teufel M, et al. (2003) Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. J. Biol. Chem. 278:6521–31.CrossRefPubMedGoogle Scholar
  7. 7.
    Zhang P, et al. (2006) Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma. Clin. Cancer Res. 12:6617–25.CrossRefPubMedGoogle Scholar
  8. 8.
    Lee JH, et al. (2012) Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer. Clin. Cancer Res. 18:524–33.CrossRefPubMedGoogle Scholar
  9. 9.
    Okamura N, et al. (2008) Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma. Proteomics. 8:3194–203.CrossRefPubMedGoogle Scholar
  10. 10.
    Tripathi A, et al. (2008) Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients. Int. J. Cancer. 122:1557–66.CrossRefPubMedGoogle Scholar
  11. 11.
    Yu G, et al. (2009) Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of Chinese patients with gastric cancer. Clin. Cancer Res. 15:1821–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Zhang Z, et al. (2012) Interleukin-11 promotes the progress of gastric carcinoma via abnormally expressed versican. Int. J. Biol. Sci. 8:383–93.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Zhang Z, et al. (2012) Wentilactone B from Aspergillus wentii induces apoptosis and inhibits proliferation and migration of human hepatoma SMMC-7721 cells. Biol. Pharm. Bull. 35:1964–71.CrossRefPubMedGoogle Scholar
  14. 14.
    Santarpia L, Lippman SM, El-Naggar AK. (2012) Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert. Opin. Ther. Targets. 16:103–19.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Wagner EF, Nebreda AR. (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer. 9:537–49.CrossRefPubMedGoogle Scholar
  16. 16.
    Otani H, Okumura N, Hashida-Okumura A, Nagai K. (2005) Identification and characterization of a mouse dipeptidase that hydrolyzes L-carnosine. J. Biochem. 137:167–75.CrossRefPubMedGoogle Scholar
  17. 17.
    Kaur H, et al. (2009) Dug1p Is a Cys-Gly peptidase of the gamma-glutamyl cycle of Saccharomyces cerevisiae and represents a novel family of Cys-Gly peptidases. J. Biol. Chem. 284:14493–502.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Licker V, et al. (2012) Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson’s disease. J. Proteomics. 75:4656–67.CrossRefPubMedGoogle Scholar
  19. 19.
    Perroud B, Ishimaru T, Borowsky AD, Weiss RH. (2009) Grade-dependent proteomics characterization of kidney cancer. Mol. Cell Proteomics. 8:971–85.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Hanahan D, Weinberg RA. (2011) Hallmarks of cancer: the next generation. Cell. 144:646–74.CrossRefGoogle Scholar
  21. 21.
    Ward PS, Thompson CB. (2012) Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 21:297–308.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Antonsson B, et al. (1997) Inhibition of Bax channel-forming activity by Bcl-2. Science. 277:370–2.CrossRefPubMedGoogle Scholar
  23. 23.
    Li Z, Yang Y, Ming M, Liu B. (2011) Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem. Biophys. Res. Commun. 414:5–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Hinds PW, et al. (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 70:993–1006.CrossRefPubMedGoogle Scholar
  25. 25.
    Okano J, Rustgi AK. (2001) Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery. J. Biol. Chem. 276:19555–64.CrossRefPubMedGoogle Scholar
  26. 26.
    Shen HM, Liu ZG. (2006) JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic. Biol. Med. 40:928–39.CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s) 2014

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (

Authors and Affiliations

  • Zhenwei Zhang
    • 1
    • 2
  • Lei Miao
    • 3
  • Xiaoming Xin
    • 3
    • 4
  • Jianpeng Zhang
    • 1
  • Shengsheng Yang
    • 1
  • Mingyong Miao
    • 1
  • Xiangping Kong
    • 2
  • Binghua Jiao
    • 1
  1. 1.Department of Biochemistry and Molecular BiologySecond Military Medical UniversityShanghaiChina
  2. 2.Key Laboratory of Liver Disease, Center of Infectious DiseasesGuangzhou 458 HospitalGuangzhouChina
  3. 3.Department of Pharmacology, School of Pharmacy and Institute of Biomedical SciencesFudan UniversityShanghaiChina
  4. 4.Department of PharmacologyTaishan Medical UniversityShandong ProvinceChina

Personalised recommendations